Multi-modal Imaging of Myofascial Pain - Phase 2
ConditionMyofascial Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorWashington University School of Medicine
About this trial
The goal of this study is to evaluate imaging biomarkers for quantitative assessments of myofascial pain and determine their ability to monitor treatment response and predict clinical outcomes.
Eligibility criteria
Qualifiers
Adults between the ages of 18 and 80 years old.
History of spontaneous (non-provoked) pain in the neck and/or shoulder region lasting at least 3 months. Neck and/or shoulder pain, unilateral or bilateral.
Presence of a palpable myofascial trigger point (MTrP) in one or both upper trapezius muscles.
The participant has a Numeric Pain Rating Scale of 4/10 or more in the last one week, and the pain is reproducible by palpating the trigger point.
Disqualifiers
Age <18 or >80 years old.
Acute cervical spine pathology, trauma (e.g. whiplash) or cervical radiculopathy
History of surgery involving the head, neck, or shoulder girdle.
Presence of neuromuscular pathologies or inflammatory muscle diseases (e.g. dermatomyositis)
Trial design
Treatments tested in this trial
- 50/50 Mixture of Lidocaine 1% injection + Bupivacaine 0.25% Injectable Solution
- Dry Needling
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Washington University School of Medicine
Lead sponsor
National Center for Complementary and Integrative Health (NCCIH)
Collaborator
Source ClinicalTrials.gov